Big headlines this week in the world of mushrooms, as a major country is starting to allow for psychiatrists to prescribe psilocybin for specific conditions. Is this a really big deal? Or just more of the same? In this episode of The Mushroom Show, we dig into the story behind Australia's re-scheduling, and how that might impact policy going forward. We're also looking at the announcement of 3 brand new studies into psilocybin assisted psychotherapy funded by the Government of Canada, plus, trying to figure out why one of the most promising myco-technology innovations was just forced to cease operations.
0:00 Intro
1:04 Did Australia Just Legalize Psilocybin?
5:19 Canada Investing $3M
13:17 Myco-Techonology Is Hard To Scale
18:29 Outro
Big headlines this week in the world of mushrooms, as a major country is starting to allow for psychiatrists to prescribe psilocybin for specific conditions. Is this a really big deal? Or just more of the same? In this episode of The Mushroom Show, we dig into the story behind Australia's re-scheduling, and how that might impact policy going forward. We're also looking at the announcement of 3 brand new studies into psilocybin assisted psychotherapy funded by the Government of Canada, plus, trying to figure out why one of the most promising myco-technology innovations was just forced to cease operations.
0:00 Intro
1:04 Did Australia Just Legalize Psilocybin?
5:19 Canada Investing $3M
13:17 Myco-Techonology Is Hard To Scale
18:29 Outro